Using in vivo PDX subcutaneous mouse models and in vitro models, the combination of CAR-T cells targeting MUC-1 and PSCA substantially inhibited tumor growth and PSCA- and MUC-1–expressing NSCLC cell proliferation (51). This evidence concerns the gene MUC1 and neoplasm.